← Back to Search

Behavioral Intervention

Care Navigation for Addiction (ABC-SUD Trial)

Seattle, WA
N/A
Waitlist Available
Led By Joseph E Glass, PhD, MSW
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is 18 years of age or older at the time of the visit
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 days
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve access to treatment for substance use disorder. It will involve care coordinators at a mental health access center in Washington. Patients seeking help for substance use disorder will either receive standard care

See full description
Who is the study for?
This trial is for individuals seeking treatment for substance use disorders at a mental health access center within the Washington region of Kaiser Permanente. Participants must be contacting the center to get an appointment or information about treatment options.Check my eligibility
What is being tested?
The study tests 'Care Navigation'—a support process by special care navigators aimed at improving patient engagement in substance use disorder treatments, compared to usual care coordination.See study design
What are the potential side effects?
Since this trial involves care coordination rather than medication, there are no direct medical side effects. However, participants may experience stress or anxiety related to navigating their treatment options.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Engagement in treatment for substance use disorder
Secondary study objectives
Initiation of treatment for substance use disorder

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Care NavigationExperimental Treatment1 Intervention
Mental health care coordinators are able to offer and refer patients to a care navigator in addition to offering substance use resources and treatment options as usual.
Group II: Services as UsualActive Control1 Intervention
Mental health care coordinators will continue offering substance use resources and treatment options to patients as usual.

Find a Location

Closest Location:Kaiser Permanente Washington· Seattle, WA· 2011 miles

Who is running the clinical trial?

Stanford UniversityOTHER
2,516 Previous Clinical Trials
17,421,179 Total Patients Enrolled
Kaiser PermanenteLead Sponsor
561 Previous Clinical Trials
27,399,336 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,641 Previous Clinical Trials
3,407,596 Total Patients Enrolled
Joseph E Glass, PhD, MSWPrincipal InvestigatorKaiser Permanente
3 Previous Clinical Trials
14,592 Total Patients Enrolled
~240 spots leftby Aug 2026